Diagnosis and treatment of cardiac amyloidosis: a position statement of the ESC Working Group on Myocardial and Pericardial Diseases
Pablo García-Pavía
1, 2, 3
,
Claudio Rapezzi
4, 5
,
Yehuda Adler
6
,
Michael Arad
7
,
Cristina Basso
3, 8, 9
,
Antonio Brucato
10
,
Ivana Burazor
11
,
A. L. P. CAFORIO
3, 12
,
Thibaud Damy
3, 13
,
U Erikkson
14
,
Marianna Fontana
15
,
Julian D. Gillmore
15
,
Esther Gonzalez-Lopez
1, 3
,
Martha Grogan
16
,
Stephane Heymans
17, 18, 19
,
Massimo Imazio
20
,
Ingrid Kindermann
21
,
Arnt V Kristen
22, 23
,
Mathew S. Maurer
24
,
G Merlini
25, 26
,
Antonis Pantazis
27
,
Sabine Pankuweit
28
,
Angelos G. Rigopoulos
29
,
Ales Linhart
30
1
3
European Reference Network for Rare, Low Prevalence and Complex Diseases of the Heart-ERN GUARD-Heart
6
8
Cardiovascular Pathology Unit, University Hospital , Padua, Italy
|
11
13
French Referral Centre for Cardiac Amyloidosis, Amyloidosis Mondor Network, GRC Amyloid Research Institute, CHU Henri Mondor , Créteil, France
|
20
Cardiovascular and Thoracic Department, University Cardiology, AOU Città della Salute e della Scienza di Torino , Torino, Italy
|
23
Cardiovascular Centre Darmstadt , Heidelberg, Germany
|
24
25
Amyloidosis Research and Treatment Centre, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Policlinico San Matteo, Pavia, Italy
|
27
Cardiomyopathy Service, Royal Brompton Hospital , London, UK
|
Publication type: Journal Article
Publication date: 2021-04-07
scimago Q1
wos Q1
SJR: 4.987
CiteScore: 40.3
Impact factor: 35.6
ISSN: 0195668X, 15229645
PubMed ID:
33825853
Cardiology and Cardiovascular Medicine
Abstract
Cardiac amyloidosis is a serious and progressive infiltrative disease that is caused by the deposition of amyloid fibrils at the cardiac level. It can be due to rare genetic variants in the hereditary forms or as a consequence of acquired conditions. Thanks to advances in imaging techniques and the possibility of achieving a non-invasive diagnosis, we now know that cardiac amyloidosis is a more frequent disease than traditionally considered. In this position paper the Working Group on Myocardial and Pericardial Disease proposes an invasive and non-invasive definition of cardiac amyloidosis, addresses clinical scenarios and situations to suspect the condition and proposes a diagnostic algorithm to aid diagnosis. Furthermore, we also review how to monitor and treat cardiac amyloidosis, in an attempt to bridge the gap between the latest advances in the field and clinical practice.
Found
Nothing found, try to update filter.
Found
Nothing found, try to update filter.
Top-30
Journals
|
5
10
15
20
25
30
35
40
|
|
|
Journal of Clinical Medicine
37 publications, 4.17%
|
|
|
ESC heart failure
34 publications, 3.83%
|
|
|
European Journal of Heart Failure
26 publications, 2.93%
|
|
|
Frontiers in Cardiovascular Medicine
24 publications, 2.7%
|
|
|
European Heart Journal Cardiovascular Imaging
23 publications, 2.59%
|
|
|
International Journal of Cardiology
22 publications, 2.48%
|
|
|
European Heart Journal - Case Reports
22 publications, 2.48%
|
|
|
Journal of Nuclear Cardiology
18 publications, 2.03%
|
|
|
Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis
18 publications, 2.03%
|
|
|
Biomedicines
16 publications, 1.8%
|
|
|
Journal of Cardiovascular Development and Disease
16 publications, 1.8%
|
|
|
European Heart Journal
15 publications, 1.69%
|
|
|
European Journal of Nuclear Medicine and Molecular Imaging
14 publications, 1.58%
|
|
|
Cureus
13 publications, 1.46%
|
|
|
Diagnostics
12 publications, 1.35%
|
|
|
Revista española de cardiología (English ed.)
12 publications, 1.35%
|
|
|
Revista Espanola de Cardiologia
12 publications, 1.35%
|
|
|
Medicina Clínica (English Edition)
11 publications, 1.24%
|
|
|
Medicina Clinica
11 publications, 1.24%
|
|
|
Heart Failure Clinics
10 publications, 1.13%
|
|
|
JACC Advances
10 publications, 1.13%
|
|
|
International Journal of Cardiovascular Imaging
9 publications, 1.01%
|
|
|
Heart Failure Reviews
8 publications, 0.9%
|
|
|
Journal of the American College of Cardiology
8 publications, 0.9%
|
|
|
European Heart Journal Open
8 publications, 0.9%
|
|
|
ABC Heart Failure & Cardiomyopathy
8 publications, 0.9%
|
|
|
JACC: Cardiovascular Imaging
7 publications, 0.79%
|
|
|
American Journal of Cardiology
7 publications, 0.79%
|
|
|
European Journal of Internal Medicine
7 publications, 0.79%
|
|
|
5
10
15
20
25
30
35
40
|
Publishers
|
50
100
150
200
250
|
|
|
Elsevier
244 publications, 27.48%
|
|
|
Springer Nature
140 publications, 15.77%
|
|
|
MDPI
93 publications, 10.47%
|
|
|
Wiley
88 publications, 9.91%
|
|
|
Oxford University Press
83 publications, 9.35%
|
|
|
Taylor & Francis
33 publications, 3.72%
|
|
|
Ovid Technologies (Wolters Kluwer Health)
31 publications, 3.49%
|
|
|
Frontiers Media S.A.
31 publications, 3.49%
|
|
|
Sociedade Brasileira de Cardiologia
14 publications, 1.58%
|
|
|
The Japanese Circulation Society
11 publications, 1.24%
|
|
|
SAGE
9 publications, 1.01%
|
|
|
AME Publishing Company
7 publications, 0.79%
|
|
|
IMR Press
7 publications, 0.79%
|
|
|
Cold Spring Harbor Laboratory
6 publications, 0.68%
|
|
|
Georg Thieme Verlag KG
5 publications, 0.56%
|
|
|
Society of Nuclear Medicine
4 publications, 0.45%
|
|
|
BMJ
4 publications, 0.45%
|
|
|
Mark Allen Group
3 publications, 0.34%
|
|
|
Baishideng Publishing Group
3 publications, 0.34%
|
|
|
Silicea - Poligraf, LLC
3 publications, 0.34%
|
|
|
The Japanese Society of Nuclear Cardiology
3 publications, 0.34%
|
|
|
F1000 Research
2 publications, 0.23%
|
|
|
Nippon-Shinzobyo-Gakkai/Japanese College of Cardiology
2 publications, 0.23%
|
|
|
American Society of Echocardiography
2 publications, 0.23%
|
|
|
Methodist DeBakey Heart & Vascular Center
2 publications, 0.23%
|
|
|
Massachusetts Medical Society
2 publications, 0.23%
|
|
|
British Institute of Radiology
2 publications, 0.23%
|
|
|
Eco-Vector LLC
2 publications, 0.23%
|
|
|
The Institute of Internal and Preventive Medicine
2 publications, 0.23%
|
|
|
50
100
150
200
250
|
- We do not take into account publications without a DOI.
- Statistics recalculated weekly.
Are you a researcher?
Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
888
Total citations:
888
Citations from 2024:
531
(59.8%)
Cite this
GOST |
RIS |
BibTex |
MLA
Cite this
GOST
Copy
García-Pavía P. et al. Diagnosis and treatment of cardiac amyloidosis: a position statement of the ESC Working Group on Myocardial and Pericardial Diseases // European Heart Journal. 2021. Vol. 42. No. 16. pp. 1554-1568.
GOST all authors (up to 50)
Copy
García-Pavía P., Rapezzi C., Adler Y., Arad M., Basso C., Brucato A., Burazor I., CAFORIO A. L. P., Damy T., Erikkson U., Fontana M., Gillmore J. D., Gonzalez-Lopez E., Grogan M., Heymans S., Imazio M., Kindermann I., Kristen A. V., Maurer M. S., Merlini G., Pantazis A., Pankuweit S., Rigopoulos A. G., Linhart A. Diagnosis and treatment of cardiac amyloidosis: a position statement of the ESC Working Group on Myocardial and Pericardial Diseases // European Heart Journal. 2021. Vol. 42. No. 16. pp. 1554-1568.
Cite this
RIS
Copy
TY - JOUR
DO - 10.1093/eurheartj/ehab072
UR - https://doi.org/10.1093/eurheartj/ehab072
TI - Diagnosis and treatment of cardiac amyloidosis: a position statement of the ESC Working Group on Myocardial and Pericardial Diseases
T2 - European Heart Journal
AU - García-Pavía, Pablo
AU - Rapezzi, Claudio
AU - Adler, Yehuda
AU - Arad, Michael
AU - Basso, Cristina
AU - Brucato, Antonio
AU - Burazor, Ivana
AU - CAFORIO, A. L. P.
AU - Damy, Thibaud
AU - Erikkson, U
AU - Fontana, Marianna
AU - Gillmore, Julian D.
AU - Gonzalez-Lopez, Esther
AU - Grogan, Martha
AU - Heymans, Stephane
AU - Imazio, Massimo
AU - Kindermann, Ingrid
AU - Kristen, Arnt V
AU - Maurer, Mathew S.
AU - Merlini, G
AU - Pantazis, Antonis
AU - Pankuweit, Sabine
AU - Rigopoulos, Angelos G.
AU - Linhart, Ales
PY - 2021
DA - 2021/04/07
PB - Oxford University Press
SP - 1554-1568
IS - 16
VL - 42
PMID - 33825853
SN - 0195-668X
SN - 1522-9645
ER -
Cite this
BibTex (up to 50 authors)
Copy
@article{2021_García-Pavía,
author = {Pablo García-Pavía and Claudio Rapezzi and Yehuda Adler and Michael Arad and Cristina Basso and Antonio Brucato and Ivana Burazor and A. L. P. CAFORIO and Thibaud Damy and U Erikkson and Marianna Fontana and Julian D. Gillmore and Esther Gonzalez-Lopez and Martha Grogan and Stephane Heymans and Massimo Imazio and Ingrid Kindermann and Arnt V Kristen and Mathew S. Maurer and G Merlini and Antonis Pantazis and Sabine Pankuweit and Angelos G. Rigopoulos and Ales Linhart},
title = {Diagnosis and treatment of cardiac amyloidosis: a position statement of the ESC Working Group on Myocardial and Pericardial Diseases},
journal = {European Heart Journal},
year = {2021},
volume = {42},
publisher = {Oxford University Press},
month = {apr},
url = {https://doi.org/10.1093/eurheartj/ehab072},
number = {16},
pages = {1554--1568},
doi = {10.1093/eurheartj/ehab072}
}
Cite this
MLA
Copy
García-Pavía, Pablo, et al. “Diagnosis and treatment of cardiac amyloidosis: a position statement of the ESC Working Group on Myocardial and Pericardial Diseases.” European Heart Journal, vol. 42, no. 16, Apr. 2021, pp. 1554-1568. https://doi.org/10.1093/eurheartj/ehab072.